Aplisens (LTS:0MMN) EBIT: zł19.7 Mil (TTM As of Mar. 2026)

What is Aplisens EBIT?

Aplisens LTS:0MMN 76 EBIT is zł19.7 Mil as of Mar. 2026. GuruFocus rates LTS:0MMN with a GF Score™ of 76/100 and a GF Value™ of zł21.20. The stock has 4 warning signs investors should review.

Aplisens's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was zł5.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was zł19.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aplisens's annualized ROC % for the quarter that ended in Mar. 2026 was 7.46%. Aplisens's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aplisens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.96%.

Aplisens (LTS:0MMN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aplisens's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	19.308 * ( 1 - 20.09% )	/	( (206.494	+	207.139)	/ 2 )
=	15.4290228	/	206.8165
=	7.46 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	243.203	-	7.418	-	( 29.291	-	max(0, 8.596	-	125.98	+	29.291	))
=	206.494

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	253.135	-	9.656	-	( 36.34	-	max(0, 10.8	-	136.941	+	36.34	))
=	207.139

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Aplisens's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	20.208	/	( ( (84.991 + max(88.093, 0))	+	(83.491 + max(89.801, 0)) )	/	2 )
=	20.208	/	( ( 173.084	+	173.292 )	/	2 )
=	20.208	/	173.188
=	11.67 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(22.588	+	71.211	+	2.89)	-	(7.418	+	0	+	1.178)
=	88.093

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(25.589	+	71.808	+	3.204)	-	(9.656	+	0	+	1.144)
=	89.801

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aplisens's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	19.711	/	197.957
	=	9.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aplisens EBIT Related Terms

Aplisens EBIT Historical Data

* Premium members only.

The historical data trend for Aplisens's EBIT can be seen below:

Aplisens EBIT Chart

Aplisens Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

21.28

25.86

40.60

26.82

19.75

Aplisens Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															5.09	5.71	5.31	3.64	5.05

LTS:0MMN vs COHR, KEYS, GRMN: EBIT Comparison

For the Scientific & Technical Instruments subindustry, Aplisens's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aplisens EV-to-EBIT vs Hardware Industry

For the Hardware industry and Technology sector, Aplisens's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aplisens's EV-to-EBIT falls into.

Save Embed

76GF Score

Aplisens SA LTS:0MMN

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aplisens EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł19.7 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of zł19.7 Mil mean?

Aplisens (LTS:0MMN) has a EBIT of zł19.7 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aplisens.

Is Aplisens' EBIT too high?

Aplisens' current EBIT is zł19.7 Mil. Overall, Aplisens has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.

How does Aplisens' EBIT compare to COHR and KEYS?

Aplisens' EBIT of zł19.7 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Hardware company?

A good EBIT depends on the Hardware industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aplisens. Aplisens's current EBIT is zł19.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aplisens stock overvalued right now?

Aplisens (LTS:0MMN) has a current EBIT of zł19.7 Mil. The stock's GF Value™ is zł21.20, compared to a current price of zł21.50 — trading 1.4% above its estimated fair value. The current EBIT is zł19.7 Mil. Aplisens' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Aplisens (LTS:0MMN), the current EBIT is zł19.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aplisens (LTS:0MMN) Overvalued in 2026?

Based on GuruFocus' analysis, Aplisens stock appears to be overvalued. The current stock price of zł21.50 is trading 1.4% above its estimated GF Value™ of zł21.20.

Key valuation signals for LTS:0MMN:

EBIT: zł19.7 Mil
GF Value™: zł21.20 vs. price of zł21.50 (1.4% above fair value)
GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the LTS:0MMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aplisens Business Description

Industry Technology Hardware

Comparable Companies WAR:INL WAR:SON WAR:YAN WAR:CRM WAR:BHX WAR:STS WAR:SCW TSE:6861 COHR KEYS GRMN TDY TPE:2360 MKSI OSTO:HEXA B FTV TRMB SZSE:300567 CGNX ESE

Other Exchanges APN:Poland

Address Morelowa 7, Warsaw, POL, 03-192

Website http://www.aplisens.pl

Aplisens SA is engaged in manufacturing of measuring instruments. It focuses on electronic pressure and differential pressure measurement technology. The company's products include differential pressure transmitters, hydrostatic level probes, level transmitters, valves, digital indicators and power supplies.

76GF Score

Get the complete analysis for LTS:0MMN

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł21.50

Price

zł21.20

GF Value

View LTS:0MMN Analysis

See EBIT data for all stocks →